U.K. Firm Hit for Process Validation, Quality Control Shortcomings

Drug GMP Report
A A
The FDA issued a warning letter to McCallum Manufacturing for deficiencies in process validation and quality control after an inspection of the firm’s Barnsley, South Yorkshire facility.

To View This Article:

Login

Subscribe To Drug GMP Report